Canada markets closed

Option Care Health, Inc. (OPCH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
30.59+0.18 (+0.59%)
At close: 04:00PM EDT
30.59 0.00 (0.00%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close30.41
Open31.00
Bid30.52 x 300
Ask30.75 x 100
Day's Range29.37 - 31.48
52 Week Range24.23 - 35.74
Volume3,554,992
Avg. Volume1,190,472
Market Cap5.317B
Beta (5Y Monthly)1.30
PE Ratio (TTM)20.67
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024

    BANNOCKBURN, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results and Highlights Net revenue of $1,146.1 million, up 12.8% compared to $1,015.8 million in the first quarter of 2023Gross profit of $238.5 million, or 20.8% of net

  • GlobeNewswire

    Option Care Health to Announce First Quarter 2024 Financial Results and Host Conference Call

    BANNOCKBURN, Ill., April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2024 on Tuesday, April 23, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details P

  • GlobeNewswire

    Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023

    BANNOCKBURN, Ill., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights Net revenue of $1,124.4 million, up 9.5% compared to $1,027.2 million in the fourth quarter of 2022Gross profit of $247.1 million, or 22.0% o